Watson 370 10 mg (Loxapine 10 mg)

Pill imprint Watson 370 10 mg has been identified as Loxapine succinate 10 mg.

Loxapine is used in the treatment of agitation; schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 10 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for Watson 370 10 mg

Loxapine succinate 10 mg Watson 370 10 mg
Loxapine succinate 10 mg Watson 370 10 mg
Loxapine succinate
Imprint:
Watson 370
10 mg
Strength:
10 mg
Color:
White & Yellow
Size:
18.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
N - Not classified
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-0370
Inactive Ingredients:
lactose anhydrous
benzyl alcohol
butylparaben
edetate calcium disodium
gelatin
magnesium stearate
methylparaben
polacrilin potassium
propylparaben
sodium lauryl sulfate
sodium propionate
magnesium silicate
titanium dioxide
D&C Yellow No. 10
FD&C Yellow No. 6
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0901 UDL Laboratories Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)